Related Experiment Videos
The synergistic effect of smoking and serum cholesterol on coronary heart disease
Insights
Smoking and high cholesterol significantly increase coronary heart disease (CHD) risk. Targeting these combined risk factors in smokers with elevated cholesterol may improve CHD prevention efforts.
Area of Science:
- Cardiovascular Disease Epidemiology
- Behavioral Risk Factors
- Public Health Interventions
Background:
- Cigarette smoking is a primary risk factor for coronary heart disease (CHD).
- A significant portion of CHD risk among smokers remains unexplained.
- Elevated serum cholesterol is also a known risk factor for CHD.
Purpose of the Study:
- To review evidence on the synergistic interaction between smoking and elevated serum cholesterol on CHD.
- To explore the role of behavioral risk factors in both smoking and cholesterol levels.
- To identify targeted interventions for reducing CHD risk.
Main Methods:
- Systematic review of existing epidemiological and clinical studies.
- Analysis of data on CHD morbidity and mortality in relation to smoking and cholesterol.
- Examination of the behavioral components associated with these risk factors.
Main Results:
- Evidence supports a synergistic interaction between smoking and elevated serum cholesterol in increasing CHD risk.
- Serum cholesterol, like smoking, can be an indicator of underlying behavioral risk.
- The precise magnitude of this interaction requires further methodological refinement.
Conclusions:
- Behavioral interventions for smoking cessation and dietary modification are recommended.
- Target populations include over 25 million Americans who smoke and have high cholesterol.
- Focused interventions can enhance CHD risk reduction effectiveness and efficiency.
Abstract:
Cigarette smoking is a strong predictor of coronary heart disease (CHD), but much of the variance in determining which smokers will, and which will not, suffer from CHD remains unexplained. This review examines evidence of a synergistic interaction effect of smoking and elevated serum cholesterol on CHD morbidity and mortality. Evidence is also presented to support the notion that, in part, serum cholesterol, like smoking, is an index of a behavioral risk factor. Such a synergistic interaction is determined to exist, although improvements in methodology are needed to more clearly identify its magnitude. The review suggests that behavioral treatments aimed at smoking cessation and dietary modification should be focused specifically on the more than 25 million young and middle-aged Americans who smoke and have elevated serum cholesterol. In this way, such treatments may increase their effectiveness in lowering the risk of CHD (benefit) without necessarily increasing their effort (cost).